Pliant Therapeutics Inc (NASDAQ: PLRX) announced data from the INTEGRIS-PSC Phase 2a trial of bexotegrast in patients with primary sclerosing cholangitis (PSC) and suspected moderate to severe ...

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States.

Toutefois, face à la pléthore d'options disponibles sur le marché, choisir le couteau pliant idéal peut se révéler une tâche complexe. C'est précisément là que ce guide d'achat et cette ...

Plusieurs bonnes raisons motivent l’achat d’un vélo pliant, très souvent électrique. Ces vélos compacts, faciles à enfourcher et à transporter, suscitent de plus en plus l’intérêt ...

In a report released yesterday, Tiago Fauth from Wells Fargo maintained a Buy rating on Pliant Therapeutics (PLRX – Research Report), with a price target of $41.00. Tiago Fauth has given his Buy ...

Phase 2a trial results of Pliant Therapeutics' bexotegrast (PLN-74809) for idiopathic pulmonary fibrosis. Reduced lung collagen, improved FVC, and cough severity, signaling potential fibrosis ...

A l'occasion de l'IFA 2023, Honor a dévoilé le Magic V2, son nouveau smartphone pliant qui entend bien s'imposer sur ce segment disputé. De nombreux constructeurs de smartphone investissent le ...

En revanche, le nouveau modèle pliant que la firme vient de présenter, le Pixel 9 Pro Fold, sera bien disponible chez nous. Et outre le fait qu’il s’agit d’un smartphone pliant Google ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...